Prognostic impact and implications of extracapsular lymph node involvement in colorectal cancer: A systematic review with meta-analysis

Annals of Oncology

Volumn 27, Issue 1, 2016, Pages 42-48

  Veronese, N ^a   Nottegar, A ^b   Pea, A ^c   Solmi, M ^a   Stubbs, B ^d   Capelli, P ^b   Sergi, G ^a   Manzato, E ^a   Fassan, M ^a   Wood, L D ^c   Scarpa, A ^b   Luchini, Claudio ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

As well as in future oncologic staging systems; Based of these results; Ene should be considered from the gross sampling to the pathology report; In colorectal cancer

Indexed keywords

AGE DISTRIBUTION; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COLORECTAL CANCER; DISEASE FREE SURVIVAL; EXTRANODAL EXTENSION; HUMAN; INTRANODAL EXTENSION; LYMPH NODE METASTASIS; NONHUMAN; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; LYMPH NODE; META ANALYSIS; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE;

COLORECTAL NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 84960112420     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdv494     Document Type: Review

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11.
2. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual, 7th edition. New York, NY: Springer-Verlag 2010.
3. Bilchik AJ, DiNome M, Saha S et al. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg 2006; 141: 527-533.
4. Wind J, Lagarde SM, Ten Kate FJ et al. A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies. Eur J Surg Oncol 2007; 33: 401-408.
5. Alakus H, Hölscher AH, Grass G et al. Extracapsular lymph node spread: a new prognostic factor in gastric cancer. Cancer 2010; 116: 309-315.
6. Lagarde SM, ten Kate FJ, de Boer DJ et al. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus. Ann Surg Oncol 2009; 16: 447-453.
7. Griebling TL, Ozkutlu D, See WA et al. Prognostic implications of extracapsular extension of lymph node metastases in prostate cancer. Mod Pathol 1997; 10: 804-809.
8. Ahn TS, Kim HS, Jeong CW et al. Extracapsular extension of pelvic lymph node metastasis is an independent prognostic factor in bladder cancer: a systematic review and meta-analysis. Ann Surg Oncol 2015; 22: 3745-3750.
9. Stitzenberg KB, Meyer AA, Stern SL et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of non-sentinel node tumor burden. Ann Surg 2003; 237: 607-612.
10. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
11. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
12. Wells GA, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri. ca/programs/clinical_epidemiology/oxford.htm (13 July 2015, date last accessed).
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
15. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
17. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463.
18. Al Sahaf O, Myers E, Jawad M et al. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer. Dis Colon Rectum 2011; 54: 982-988.
19. Brabender J, Bollschweiler E, Hölscher AH et al. The prognostic impact of extracapsular lymph node involvement in rectal cancer patients: implications for staging and adjuvant treatment strategies. Oncol Lett 2012; 3: 825-830.
20. Demir L, Ekinci N, Erten C et al. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer. J Surg Oncol 2014; 109: 665-675.
21. Fujii T, Tabe Y, Yajima R et al. Extracapsular invasion as a risk factor for disease recurrence in colorectal cancer. World J Gastroenterol 2011; 17: 2003-2006.
22. Heide J, Krüll A, Berger J. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer. Int J Radiat Oncol Biol Phys 2004; 58: 773-778.
23. Komori K, Kanemitsu Y, Kimura K et al. Detailed stratification of TNM stage III rectal cancer based on the presence/absence of extracapsular invasion of the metastatic lymph nodes. Dis Colon Rectum 2013; 56: 726-732.
24. Komuta K, Okudaira S, Haraguchi M et al. Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer. Dis Colon Rectum 2001; 44: 1838-1844.
25. Lupattelli M, Maranzano E, Bellavita R et al. Adjuvant radiochemotherapy in highrisk rectal cancer results of a prospective non-randomized study. Tumori 2001; 87: 239-247.
26. Puppa G, Maisonneuve P, Sonzogni A et al. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol 2007; 20: 843-855.
27. Suzuki H, Fujii T, Asao T et al. Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases. World J Surg 2014; 38: 2079-2088.
28. Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998; 41: 55-61.
29. Wind J, ten Kate FJ, Kiewiet JJ et al. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol 2008; 34: 390-396.
30. Yano H, Saito Y, Kirihara Y, Takashima J. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma. Dis Colon Rectum 2006; 49: 1867-1877.
31. Luchini C, Nottegar A, Solmi M et al. Prognostic implications of extranodal extension in node-positive squamous cell carcinoma of the vulva: a systematic review and meta-analysis. Surg Oncol 2015 Sep 14 [epub ahead of print], doi: 10.1016/j.suronc.2015.09.005.
32. Luchini C, Capelli P, Fassan M et al. Next generation histopathologic diagnosis: a lesson from a hepatic carcinosarcoma. J Clin Oncol 2014; 10; 32: e63-e66.